Style
ValueTurnover
Orientation
Concentrated trader| # | Security | Shares | Value | % of Portfolio |
|---|---|---|---|---|
| 1 | Veradermics, Inc.(MANE) | 2,401,868 | $295.3M | 28.42% |
| 2 | Zenas BioPharma, Inc(ZBIO) | 5,037,854 | $127.9M | 12.31% |
| 3 | Crispr Therapeutics AG(CRSP) | 2,038,763 | $111.2M | 10.70% |
| 4 | Avalyn Pharma, Inc(AVLN) | 3,308,649 | $108.9M | 10.48% |
| 5 | Design Therapeutics, Inc.(DSGN) | 6,526,476 | $94.4M | 9.09% |
Latest filing, equity positions only
Quarter-over-quarter weight changes
| Sector | Prev % | Curr % | Change |
|---|---|---|---|
| Healthcare | 70.98% | 40.14% | -30.84% |
| Unclassified | 29.02% | 59.86% | +30.84% |
Quarter-over-quarter weight changes by market cap
| 6 |
| Odyssey Therapeutics, Inc.(ODTX) |
| 3,794,883 |
| $71.0M |
| 6.83% |
| 7 | Alumis Inc.(ALMS) | 1,959,896 | $55.2M | 5.31% |
| 8 | Oric Pharmaceuticals, Inc.(ORIC) | 4,615,384 | $50.0M | 4.81% |
| 9 | Mineralys Therapeutics Inc.(MLYS) | 1,563,966 | $42.2M | 4.06% |
| 10 | ARS Pharmaceuticals, Inc.(SPRY) | 4,012,903 | $32.1M | 3.09% |
| Cap Size | Prev % | Curr % | Change |
|---|---|---|---|
| Unclassified | 29.02% | 59.86% | +30.84% |
| Small Cap | 36.06% | 33.93% | -2.13% |
| Mid Cap | 34.15% | 5.31% | -28.84% |
| Micro Cap | 0.77% | 0.91% | +0.14% |
Quarter-over-quarter position changes